Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alfapump DSR System in the Treatment of Diuretic Resistant Heart Failure Subjects

NCT04116034 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.

NCT NCT04116034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04116034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alfapump DSR System in the Treatment of Diuretic Resistant Heart Failure Subjects
Lead sponsor
Sequana Medical N.V.
Phase
Not applicable
Overall status
Completed
Start date
December 26, 2019
Completion date
April 15, 2021
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiorenal syndrome, congestive heart failure, heart failure, sodium disorder, sodium excess, volume overload